Both in Pharmaceuticals
Kyntra Bio vs Context Therapeutics
Over the past year KYNB returned −54.2% and CNTX returned −87.3%; their daily moves had a correlation of 0.05.
KYNB −54.2% CNTX −87.3%Growth of $1, one year, split-adjusted
| Metric | KYNB | CNTX |
|---|---|---|
| Price | $4.35 | $0.2027 |
| Market cap | $17.6M | $18.6M |
| Today | −2.47% | +0.35% |
| 1 month | −28.6% | −39.8% |
| 6 months | −38.7% | −91.7% |
| Year to date | — | −86.2% |
| 1 year | — | −81.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $91.3M | $43.0M |
| Dividend yield | — | — |
| Volatility (60d) | 54.9% | 69.3% |
| Short % of float | 2.5% | 6.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).